Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition

被引:64
作者
Keserue, Benjamin [1 ]
Barbosa-Sicard, Eduardo [1 ]
Schermuly, Ralph T. [2 ,3 ]
Tanaka, Hiromasa [4 ]
Hammock, Bruce D. [4 ]
Weissmann, Norbert [2 ]
Fisslthaler, Beate [1 ]
Fleming, Ingrid [1 ]
机构
[1] Goethe Univ Frankfurt, Inst Vasc Signalling, D-60590 Frankfurt, Germany
[2] Univ Giessen, Dept Internal Med 2 5, Lung Ctr, Giessen, Germany
[3] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodeling, Bad Nauheim, Germany
[4] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA
关键词
Cytochrome P450; Epoxyeicosatrienoic acid; Hypoxia; Pulmonary hypertension; Soluble epoxide hydrolase; EPOXYEICOSATRIENOIC ACIDS; EXPRESSION; VASOCONSTRICTION; PHOSPHATASE; STROKE; POLYMORPHISMS; PRESSURE; REVEALS; RISK; MICE;
D O I
10.1093/cvr/cvp281
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims The C-terminal domain of the soluble epoxide hydrolase (sEH) metabolizes epoxyeicosatrienoic acids (EETs) to their less active diols, while the N-terminal domain demonstrates lipid phosphatase activity. As EETs are potent vasoconstrictors in the pulmonary circulation, we assessed the development of pulmonary hypertension induced by exposure to hypoxia (10% O-2) for 21 days in wild-type (WT) and sEH(-/-) mice and compared the effects with chronic (4 months) sEH inhibition. Methods and results In isolated lungs from WT mice, acute hypoxic vasoconstriction (HPV) was potentiated by sEH inhibition and attenuated by an EET antagonist. After prolonged hypoxia, the acute HPV and sensitivity to the EET antagonist were increased, but potentiation of vasoconstriction following sEH inhibition was not evident. Chronic hypoxia also stimulated the muscularization of pulmonary arteries and decreased sEH expression in WT mice. In normoxic sEH(-/-) mice, acute HPV and small artery muscularization were greater than that in WT lungs and enhanced muscularization was accompanied with decreased voluntary exercise capacity. Acute HPV in sEH(-/-) mice was insensitive to sEH inhibition but inhibited by the EET antagonist and chronic hypoxia induced an exaggerated pulmonary vascular remodelling. In WT mice, chronic sEH inhibition increased serum EET levels but failed to affect acute HPV, right ventricle weight, pulmonary artery muscularization, or voluntary running distance. In human donor lungs, the sEH was expressed in the wall of pulmonary arteries, however, sEH expression was absent in samples from patients with pulmonary hypertension. Conclusion These data suggest that a decrease in sEH expression is intimately linked to pathophysiology of hypoxia-induced pulmonary remodelling and hypertension. However, as sEH inhibitors do not promote the development of pulmonary hypertension it seems likely that the N-terminal lipid phosphatase may play a role in the development of this disease.
引用
收藏
页码:232 / 240
页数:9
相关论文
共 38 条
[21]   Structural refinement of inhibitors of urea-based soluble epoxide hydrolases [J].
Morisseau, C ;
Goodrow, MH ;
Newman, JW ;
Wheelock, CE ;
Dowdy, DL ;
Hammock, BD .
BIOCHEMICAL PHARMACOLOGY, 2002, 63 (09) :1599-1608
[22]   Hypoxic pulmonary vasoconstriction [J].
Moudgil, R ;
Michelakis, ED ;
Archer, SL .
JOURNAL OF APPLIED PHYSIOLOGY, 2005, 98 (01) :390-403
[23]   Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation [J].
Muller, Dominik N. ;
Schmidt, Cosima ;
Barbosa-Sicard, Eduardo ;
Wellner, Maren ;
Gross, Volkmar ;
Hercule, Hantz ;
Markovic, Marija ;
Honeck, Horst ;
Luft, Friedrich C. ;
Schunck, Wolf-Hagen .
BIOCHEMICAL JOURNAL, 2007, 403 :109-118
[24]   The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity [J].
Newman, JW ;
Morisseau, C ;
Harris, TR ;
Hammock, BD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :1558-1563
[25]   Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling [J].
Pokreisz, P ;
Fleming, I ;
Kiss, L ;
Barbosa-Sicard, E ;
Fisslthaler, B ;
Falck, JR ;
Hammock, BD ;
Kim, IH ;
Szelid, Z ;
Vermeersch, P ;
Gillijns, H ;
Pellens, M ;
Grimminger, F ;
van Zonneveld, AJ ;
Collen, D ;
Busse, R ;
Janssens, S .
HYPERTENSION, 2006, 47 (04) :762-770
[26]   Cytochrome P4502C9-induced endothelial cell proliferation involves induction of mitogen-activated protein (MAP) kinase phosphatase-1, inhibition of the c-Jun N-terminal kinase, and up-regulation of cyclin D1 [J].
Potente, M ;
Michaelis, UR ;
Fisslthaler, B ;
Busse, R ;
Fleming, I .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (18) :15671-15676
[27]   Polymorphisms in human soluble epoxide hydrolase [J].
Przybyla-Zawislak, BD ;
Srivastava, PK ;
Vázquez-Matías, J ;
Mohrenweiser, HW ;
Maxwell, JE ;
Hammock, BD ;
Bradbury, JA ;
Enayetallah, AE ;
Zeldin, DC ;
Grant, DF .
MOLECULAR PHARMACOLOGY, 2003, 64 (02) :482-490
[28]   Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats [J].
Revermann, Marc ;
Barbosa-Sicard, Eduardo ;
Dony, Eva ;
Schermuly, Ralph T. ;
Morisseau, Christophe ;
Geisslinger, Gerd ;
Fleming, Ingrid ;
Hammock, Bruce D. ;
Brandes, Ralf P. .
JOURNAL OF HYPERTENSION, 2009, 27 (02) :322-331
[29]   Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation [J].
Sinal, CJ ;
Miyata, M ;
Tohkin, M ;
Nagata, K ;
Bend, JR ;
Gonzalez, FJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (51) :40504-40510
[30]   Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor [J].
Smith, KR ;
Pinkerton, KE ;
Watanabe, T ;
Pedersen, TL ;
Ma, SJ ;
Hammock, BD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (06) :2186-2191